British Sarcoma Group

Executive Office 35 Sandford Avenue Church Stretton Shropshire SY6 6BH Telephone 01694 722123

Trial Name	EORTC 62012
Description	Phase III randomised trial of single agent doxorubicin versus doxorubicin plus ifosfamide in the first line treatment of advanced or metastatic soft tissue sarcoma.
Reference	EORTC 62012 NCRN portfolio
Status / Sites	CLOSED
UK Chief Investigator Contact	Prof Ian Judson, London EORTC data centre, Brussels

You are viewing the text version of this site.

To view the full version please install the Adobe Flash Player and ensure your web browser has JavaScript enabled.

Need help? check the requirements page.